Authors

Beyond the Prescription: How Pharmacists Address Social Barriers to Diabetes Care

Disparities in education access and quality, income level, and race and ethnicity are SDoH that make a major impact on diabetes and its management in the US.

Subcutaneous Pembrolizumab Matches IV in Lung Cancer Trial

Enriqueta Felip, MD, PhD, discussed the benefits of subcutaneous pembrolizumab for patients with metastatic non–small cell lung cancer.

Improve Skin Health Through Student Pharmacist Education

Student pharmacists boost dermatology literacy in underserved communities, improving sunscreen habits, skin cancer warning recognition, and practical skin health self-care.

Pembrolizumab-Induced Adrenal Insufficiency: Recognizing and Managing a Diagnostic Challenge in Adjuvant NSCLC Therapy

Pembrolizumab in adjuvant NSCLC therapy can trigger central adrenal insufficiency with vague fatigue, nausea, and hyponatremia.

Going with the Flow: Updates in Diabetes and Chronic Kidney Disease

CKD is a complication of diabetes. Emerging treatments aim to optimize management and reduce risks. Pharmacists are key in applying new evidence to clinical practice.

Safe Implementation of Tumor-Infiltrating Lymphocyte Therapy at an Academic Cancer Center: A Multidisciplinary and Oncology Clinical Pharmacy Specialist–Driven Approach

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

Beat the Heat: 10 Common Medication Culprits Causing Heat Intolerance

Pharmacists can educate patients on preventive measures to avoid heat-related illnesses.

Risks and Impacts of Cannabis Use During Pregnancy: A Growing Concern for Neonatal Health

Cannabis use during pregnancy may harm fetal development and long-term health.

Tec-Dara: Match Made in Heaven or Double Trouble?

FDA clears teclistamab plus daratumumab after first relapse, delivering striking PFS gains—plus practical tips to manage CRS, ICANS, and infections.

Nuclear Isotopes Could Help Address Challenges in Oncology Clinical Trials

The radiation emerging from these isotopes can be used in 2 different ways in cancer trials: imaging (detection of tumors) and therapy (destruction of tumors).

TAR-200 Demonstrates Strong Efficacy and Favorable Tolerability in BCG-Unresponsive NMIBC

At ESMO 2025, Felix Guerrero-Ramos, MD, discussed SunRISe-1 data showing durable responses and low toxicity with TAR-200, the importance of training in device management, and how future biomarker research may refine patient selection and combination strategies.

The Pharmacist’s Role in Evaluating 505(b)(2) Drugs

Pharmacists play a crucial role in evaluating 505(b)(2) drugs—from ensuring oncology therapeutic equivalence to improving access and outcomes.

Five Domains, One Outcome: How Social Factors Shape Cancer Survival

Iman Ahmed, PharmD, BCOP, shared key insights about how social determinants of health impact treatment access and outcomes for patients with leukemia.

In a Nod to Precision Oncology, the FDA Approves Revumenib

The approval marks a significant milestone in the treatment of a rare and aggressive subtype of acute leukemia.

AI and Drug Information: Where OpenEvidence Stands Out—and Where Pharmacists Still Win

Like other HCPs, pharmacists use AI-driven tools to support the delivery of pharmacy-related services.

GLP-1s: A New Frontier in Substance Use Disorder Management

New trials explore glucagon-like peptide-1 receptor agonists for alcohol, nicotine use disorder, and smoking cessation.

Better Asthma Control Starts at the Pharmacy: Evidence, Interventions, and Outcomes

Community pharmacists boost asthma control by improving adherence, inhaler technique, and access—cutting exacerbations and emergency department visits.

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Gabe Hinojosa, PharmD, BCOP, shares key data for pharmacists from the 2025 American Society of Clinical Oncology Annual Meeting.

Pharmacists Can Advance Lung Cancer Screening Awareness in High-Risk Patients

Pharmacists can help close the lung cancer screening gap by identifying high-risk tobacco users, increasing awareness, and connecting eligible patients to lifesaving early detection.

Navigating Weight Loss Medications: Long-Term Use, Discontinuation, and Maintaining Weight Loss

A holistic approach emphasizing lifestyle modifications is essential to maintain weight loss after and while stopping medication.

Emerging Targeted Therapies in Breast Cancer: Expanding HER2-Low and TROP-2 Breakthroughs Require Pharmacist Knowledge and Vigilance

ADCs are reshaping metastatic breast cancer and pharmacists' roles in treatment management.

Medical Misinformation Affects Public Understanding of Long COVID

Pharmacists Help Guide Regimen Choice Between Flu/Cy/TBI and Flu/Bu2

Monica Sawiris, PharmD, said there were noticeable differences in toxicities between each regimen.

Outcomes of Pharmacist-Driven Clinical Interventions in a Medically Integrated Oncology Specialty Pharmacy Practice

The high acceptance rates of these interventions demonstrate the key role in optimizing patient care that clinical oncology pharmacists with access to medical records play.

Cost Avoidance and Satisfaction Associated With Clinical Pharmacy Services in a Veterans Affairs Specialty Clinic

An infusion and specialty clinical pharmacist is a valuable integrated member of the health care team as demonstrated by cost avoidance and high satisfaction reported by both veterans and specialty providers.

GLP-1 Boosters: Responding to Supplement Marketing Claims and Safety Questions

OTC GLP-1 boosters are marketed for weight loss, but pharmacists should help patients distinguish evidence-based care from supplement claims.

Navigating the Growing Impact of Alternative Funding Programs, Copay Accumulators, and Maximizers on Specialty Medication Access

The ability to anticipate access delays, navigate benefit changes, and protect continuity of care has become a defining role of modern pharmacy practice.

Pharmacists Can Advance Lung Cancer Screening Awareness in High-Risk Patients

Pharmacists can help close the lung cancer screening gap by identifying high-risk tobacco users, increasing awareness, and connecting eligible patients to lifesaving early detection.

What Every Oncology Pharmacist Should Know About Gynecologic Cancer This September

This FAQ describes what oncology pharmacists should know ahead of Gynecologic Cancer Awareness Month in September.

Vaccine Timing and Safety in Patients With Neurological Diseases

This episode covers the importance of considering vaccine timing, selection, and hesitancy in patients on immunomodulating and immunosuppressive therapies, along with emerging data linking several vaccines to reduced dementia risk.